{"transactions":[{"id":305605,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T20:20:11.000Z","date":"2026-08-27","kind":"gift","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39000,"source":{"system":"sec-edgar","filing":"0000875320-26-000261","document":"wk-form4_1788207608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000261/wk-form4_1788207608.xml","form_type":"4"}},{"id":307087,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-07-17T20:06:40.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":99.941,"price":475.28,"value":47499.95848,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":15771.807,"derivative":{"underlying":"Common Stock","underlying_shares":99.941},"source":{"system":"sec-edgar","filing":"0000875320-26-000249","document":"wk-form4_1784318797.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000249/wk-form4_1784318797.xml","form_type":"4"}},{"id":310071,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:24:45.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":2866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":2866,"derivative":{"exercise_price":424.45,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":2866},"source":{"system":"sec-edgar","filing":"0000875320-26-000187","document":"wk-form4_1778016282.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000187/wk-form4_1778016282.xml","form_type":"4"}},{"id":310644,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-04-17T20:17:34.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":107.345,"price":442.5,"value":47500.1625,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":15671.866,"derivative":{"underlying":"Common Stock","underlying_shares":107.345},"source":{"system":"sec-edgar","filing":"0000875320-26-000161","document":"wk-form4_1776457052.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000161/wk-form4_1776457052.xml","form_type":"4"}},{"id":315152,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-01-20T21:45:08.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":107.088,"price":443.56,"value":47499.95328,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":15564.521,"derivative":{"underlying":"Common Stock","underlying_shares":107.088},"source":{"system":"sec-edgar","filing":"0000875320-26-000006","document":"wk-form4_1768945505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000006/wk-form4_1768945505.xml","form_type":"4"}},{"id":317936,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-10-17T20:04:06.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":115.766,"price":410.31,"value":47499.94746,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":15457.433,"derivative":{"underlying":"Common Stock","underlying_shares":115.766},"source":{"system":"sec-edgar","filing":"0000875320-25-000226","document":"wk-form4_1760731442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000226/wk-form4_1760731442.xml","form_type":"4"}},{"id":320078,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-07T20:19:03.000Z","date":"2025-08-06","kind":"purchase","planned":false,"acquired":true,"shares":3366,"price":389.84,"value":1312201.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market purchases reported on this line occurred at a weighted average price of $389.84 (range $389.61 to $390.00)."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0000875320-25-000218","document":"wk-form4_1754597921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000218/wk-form4_1754597921.xml","form_type":"4"}},{"id":320077,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-07T20:19:03.000Z","date":"2025-08-06","kind":"purchase","planned":false,"acquired":true,"shares":1634,"price":389.36,"value":636214.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $389.36 (range $388.61 to $389.60)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":41634,"source":{"system":"sec-edgar","filing":"0000875320-25-000218","document":"wk-form4_1754597921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000218/wk-form4_1754597921.xml","form_type":"4"}},{"id":320634,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-07-17T20:04:16.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":101.206,"price":469.34,"value":47500.02404,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":15341.667,"derivative":{"underlying":"Common Stock","underlying_shares":101.206},"source":{"system":"sec-edgar","filing":"0000875320-25-000208","document":"wk-form4_1752782649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000208/wk-form4_1752782649.xml","form_type":"4"}},{"id":322556,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-05T20:55:45.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":2398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":2398,"derivative":{"exercise_price":502.97,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":2398},"source":{"system":"sec-edgar","filing":"0000875320-25-000184","document":"wk-form4_1746478539.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000184/wk-form4_1746478539.xml","form_type":"4"}},{"id":323100,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-04-17T20:07:15.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":95.475,"price":497.51,"value":47499.76725,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":15240.461,"derivative":{"underlying":"Common Stock","underlying_shares":95.475},"source":{"system":"sec-edgar","filing":"0000875320-25-000164","document":"wk-form4_1744920427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000164/wk-form4_1744920427.xml","form_type":"4"}},{"id":327414,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-01-17T21:04:32.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":111.654,"price":420.31,"value":46929.29274,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":15144.986,"derivative":{"underlying":"Common Stock","underlying_shares":111.654},"source":{"system":"sec-edgar","filing":"0000875320-25-000002","document":"wk-form4_1737147865.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000002/wk-form4_1737147865.xml","form_type":"4"}},{"id":330126,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-10-17T20:12:52.000Z","date":"2024-10-15","kind":"grant","planned":false,"acquired":true,"shares":90.32,"price":484.39,"value":43750.1048,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":15033.332,"derivative":{"underlying":"Common Stock","underlying_shares":90.32},"source":{"system":"sec-edgar","filing":"0000875320-24-000216","document":"wk-form4_1729195965.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000216/wk-form4_1729195965.xml","form_type":"4"}},{"id":331696,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-02T20:10:07.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":5295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":125.71,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":5295},"source":{"system":"sec-edgar","filing":"0000875320-24-000200","document":"wk-form4_1722629400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000200/wk-form4_1722629400.xml","form_type":"4"}},{"id":331695,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-02T20:10:07.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":5295,"price":508,"value":2689860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 02/12/2024."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000875320-24-000200","document":"wk-form4_1722629400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000200/wk-form4_1722629400.xml","form_type":"4"}},{"id":331694,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-02T20:10:07.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":5295,"price":125.71,"value":665634.45,"ownership":{"direct":true},"balance_after":45295,"source":{"system":"sec-edgar","filing":"0000875320-24-000200","document":"wk-form4_1722629400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000200/wk-form4_1722629400.xml","form_type":"4"}},{"id":332070,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-07-17T20:13:27.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":89.264,"price":490.12,"value":43750.07168,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":14943.012,"derivative":{"underlying":"Common Stock","underlying_shares":89.264},"source":{"system":"sec-edgar","filing":"0000875320-24-000185","document":"wk-form4_1721247199.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000185/wk-form4_1721247199.xml","form_type":"4"}},{"id":333379,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:13:03.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":false,"shares":7073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":93.51,"expiration_date":"2026-05-31","underlying":"Common Stock","underlying_shares":7073},"source":{"system":"sec-edgar","filing":"0000875320-24-000158","document":"wk-form4_1716581569.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000158/wk-form4_1716581569.xml","form_type":"4"}},{"id":333378,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-24T20:13:03.000Z","date":"2024-05-22","kind":"sale","planned":true,"acquired":false,"shares":7073,"price":448,"value":3168704.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 02/12/2024."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000875320-24-000158","document":"wk-form4_1716581569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000158/wk-form4_1716581569.xml","form_type":"4"}},{"id":333377,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-24T20:13:03.000Z","date":"2024-05-22","kind":"exercise","planned":true,"acquired":true,"shares":7073,"price":93.51,"value":661396.23,"ownership":{"direct":true},"balance_after":47073,"source":{"system":"sec-edgar","filing":"0000875320-24-000158","document":"wk-form4_1716581569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000158/wk-form4_1716581569.xml","form_type":"4"}},{"id":334159,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T20:21:21.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":3142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":3142,"derivative":{"exercise_price":399.71,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":3142},"source":{"system":"sec-edgar","filing":"0000875320-24-000129","document":"wk-form4_1714767664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000129/wk-form4_1714767664.xml","form_type":"4"}},{"id":335089,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-04-17T20:07:46.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":109.49,"price":399.58,"value":43750.0142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":14853.748,"derivative":{"underlying":"Common Stock","underlying_shares":109.49},"source":{"system":"sec-edgar","filing":"0000875320-24-000115","document":"wk-form4_1713384457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000115/wk-form4_1713384457.xml","form_type":"4"}},{"id":342431,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-01-17T21:08:26.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":101.042,"price":432.99,"value":43750.17558,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":14744.258,"derivative":{"underlying":"Common Stock","underlying_shares":101.042},"source":{"system":"sec-edgar","filing":"0000875320-24-000008","document":"wk-form4_1705525692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000008/wk-form4_1705525692.xml","form_type":"4"}},{"id":344680,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-08T21:11:25.000Z","date":"2023-11-06","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":11250,"derivative":{"exercise_price":127.54,"expiration_date":"2025-05-31","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0000875320-23-000033","document":"wk-form4_1699477872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000033/wk-form4_1699477872.xml","form_type":"4"}},{"id":344679,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-08T21:11:25.000Z","date":"2023-11-06","kind":"sale","planned":true,"acquired":false,"shares":11250,"price":385,"value":4331250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 11/04/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $385.00 (range $385.00 to $385.02)."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000875320-23-000033","document":"wk-form4_1699477872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000033/wk-form4_1699477872.xml","form_type":"4"}},{"id":344678,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-08T21:11:25.000Z","date":"2023-11-06","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":127.54,"value":1434825.0,"ownership":{"direct":true},"balance_after":51250,"source":{"system":"sec-edgar","filing":"0000875320-23-000033","document":"wk-form4_1699477872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000033/wk-form4_1699477872.xml","form_type":"4"}},{"id":345189,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-10-17T20:19:42.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":118.25,"price":369.98,"value":43750.135,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":14643.216,"derivative":{"underlying":"Common Stock","underlying_shares":118.25},"source":{"system":"sec-edgar","filing":"0001209191-23-052961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123052961/doc4.xml","form_type":"4"}},{"id":347485,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-18T20:17:01.000Z","date":"2023-07-17","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":11250,"derivative":{"exercise_price":127.54,"expiration_date":"2025-05-31","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001209191-23-042566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123042566/doc4.xml","form_type":"4"}},{"id":347484,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-07-18T20:17:01.000Z","date":"2023-07-14","kind":"grant","planned":true,"acquired":true,"shares":124.719,"price":350.79,"value":43750.17801,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":14524.966,"derivative":{"underlying":"Common Stock","underlying_shares":124.719},"source":{"system":"sec-edgar","filing":"0001209191-23-042566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123042566/doc4.xml","form_type":"4"}},{"id":347483,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-18T20:17:01.000Z","date":"2023-07-17","kind":"sale","planned":true,"acquired":false,"shares":3842,"price":357.29,"value":1372708.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 11/04/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $357.29 (range $357.00 to $357.38)."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-23-042566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123042566/doc4.xml","form_type":"4"}},{"id":347482,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-18T20:17:01.000Z","date":"2023-07-17","kind":"sale","planned":true,"acquired":false,"shares":5711,"price":356.75,"value":2037399.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 11/04/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $356.75 (range $356.00 to $356.99)."}],"balance_after":43842,"source":{"system":"sec-edgar","filing":"0001209191-23-042566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123042566/doc4.xml","form_type":"4"}},{"id":347481,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-18T20:17:01.000Z","date":"2023-07-17","kind":"sale","planned":true,"acquired":false,"shares":1697,"price":355.54,"value":603351.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 11/04/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $355.54 (range $355.00 to $355.97)."}],"balance_after":49553,"source":{"system":"sec-edgar","filing":"0001209191-23-042566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123042566/doc4.xml","form_type":"4"}},{"id":347480,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-18T20:17:01.000Z","date":"2023-07-17","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":127.54,"value":1434825.0,"ownership":{"direct":true},"balance_after":51250,"source":{"system":"sec-edgar","filing":"0001209191-23-042566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123042566/doc4.xml","form_type":"4"}},{"id":349488,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-03T21:05:45.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":3481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":3481,"derivative":{"exercise_price":342.73,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":3481},"source":{"system":"sec-edgar","filing":"0001209191-23-027056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123027056/doc4.xml","form_type":"4"}},{"id":350051,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-04-18T21:14:16.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":131.473,"price":332.77,"value":43750.27021,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":14400.247,"derivative":{"underlying":"Common Stock","underlying_shares":131.473},"source":{"system":"sec-edgar","filing":"0001209191-23-024711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123024711/doc4.xml","form_type":"4"}},{"id":350303,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-14T20:14:39.000Z","date":"2023-04-12","kind":"exercise","planned":true,"acquired":false,"shares":21300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested"}],"balance_after":0,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":21300},"source":{"system":"sec-edgar","filing":"0001209191-23-024305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123024305/doc4.xml","form_type":"4"}},{"id":350302,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-14T20:14:39.000Z","date":"2023-04-13","kind":"gift","planned":true,"acquired":false,"shares":1210,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-23-024305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123024305/doc4.xml","form_type":"4"}},{"id":350301,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-14T20:14:39.000Z","date":"2023-04-12","kind":"sale","planned":true,"acquired":false,"shares":8026,"price":327.48,"value":2628354.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 11/04/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $327.48 (range $327.00 to $327.93)."}],"balance_after":41210,"source":{"system":"sec-edgar","filing":"0001209191-23-024305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123024305/doc4.xml","form_type":"4"}},{"id":350300,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-14T20:14:39.000Z","date":"2023-04-12","kind":"sale","planned":true,"acquired":false,"shares":10357,"price":326.46,"value":3381146.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 11/04/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $326.46 (range $326.00 to $326.97)."}],"balance_after":49236,"source":{"system":"sec-edgar","filing":"0001209191-23-024305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123024305/doc4.xml","form_type":"4"}},{"id":350299,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-14T20:14:39.000Z","date":"2023-04-12","kind":"sale","planned":true,"acquired":false,"shares":2917,"price":325.65,"value":949921.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 11/04/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $325.65 (range $325.00 to $325.99)."}],"balance_after":59593,"source":{"system":"sec-edgar","filing":"0001209191-23-024305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123024305/doc4.xml","form_type":"4"}},{"id":350298,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-14T20:14:39.000Z","date":"2023-04-12","kind":"exercise","planned":true,"acquired":true,"shares":21300,"price":72.14,"value":1536582.0,"ownership":{"direct":true},"balance_after":62510,"source":{"system":"sec-edgar","filing":"0001209191-23-024305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123024305/doc4.xml","form_type":"4"}},{"id":354216,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T21:14:45.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":21300,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001209191-23-006204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006204/doc4.xml","form_type":"4"}},{"id":354215,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T21:14:45.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":1200,"price":325.01,"value":390012.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $325.01 (range $325.00 to $325.01)."}],"balance_after":41210,"source":{"system":"sec-edgar","filing":"0001209191-23-006204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006204/doc4.xml","form_type":"4"}},{"id":354214,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T21:14:45.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":1200,"price":72.14,"value":86568.0,"ownership":{"direct":true},"balance_after":42410,"source":{"system":"sec-edgar","filing":"0001209191-23-006204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006204/doc4.xml","form_type":"4"}},{"id":354797,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-01-18T21:15:52.000Z","date":"2023-01-13","kind":"grant","acquired":true,"shares":146.606,"price":298.42,"value":43750.16252,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":14268.774,"derivative":{"underlying":"Common Stock","underlying_shares":146.606},"source":{"system":"sec-edgar","filing":"0001209191-23-003726","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123003726/doc4.xml","form_type":"4"}},{"id":357458,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-10-18T20:27:32.000Z","date":"2022-10-14","kind":"grant","acquired":true,"shares":147.396,"price":296.82,"value":43750.08072,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":14122.168,"derivative":{"underlying":"Common Stock","underlying_shares":147.396},"source":{"system":"sec-edgar","filing":"0000899243-22-033744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322033744/doc4.xml","form_type":"4"}},{"id":359707,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-07-19T20:35:22.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":151.264,"price":289.23,"value":43750.08672,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":13974.772,"derivative":{"underlying":"Common Stock","underlying_shares":151.264},"source":{"system":"sec-edgar","filing":"0000899243-22-026349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322026349/doc4.xml","form_type":"4"}},{"id":361995,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-03T20:43:02.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":4462,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4462,"derivative":{"exercise_price":276.17,"exercise_date":"2022-05-01","expiration_date":"2032-04-30","underlying":"Common Stock","underlying_shares":4462},"source":{"system":"sec-edgar","filing":"0000899243-22-016331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016331/doc4.xml","form_type":"4"}},{"id":362648,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-04-18T20:05:13.000Z","date":"2022-04-14","kind":"grant","acquired":true,"shares":151.17,"price":289.41,"value":43750.1097,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":13823.508,"derivative":{"underlying":"Common Stock","underlying_shares":151.17},"source":{"system":"sec-edgar","filing":"0000899243-22-014960","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014960/doc4.xml","form_type":"4"}},{"id":367342,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-01-19T21:24:55.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":189.739,"price":230.58,"value":43750.01862,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":13672.338,"derivative":{"underlying":"Common Stock","underlying_shares":189.739},"source":{"system":"sec-edgar","filing":"0001209191-22-003721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122003721/doc4.xml","form_type":"4"}},{"id":370560,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-10-18T20:08:14.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":240.293,"price":182.07,"value":43750.14651,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":13482.599,"derivative":{"underlying":"Common Stock","underlying_shares":240.293},"source":{"system":"sec-edgar","filing":"0001209191-21-060705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121060705/doc4.xml","form_type":"4"}},{"id":372749,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-04T20:05:43.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":15000,"price":197.91,"value":2968650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market sales reported on this line occurred at a weighted average price of $197.91 (range $197.45 to $198.12)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":41210,"source":{"system":"sec-edgar","filing":"0001209191-21-049602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121049602/doc4.xml","form_type":"4"}},{"id":373511,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-07-16T20:08:21.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":220.96,"price":198,"value":43750.08,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":13242.306,"derivative":{"underlying":"Common Stock","underlying_shares":220.96},"source":{"system":"sec-edgar","filing":"0001209191-21-046903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121046903/doc4.xml","form_type":"4"}},{"id":376072,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-04T20:20:36.000Z","date":"2021-05-01","kind":"grant","acquired":true,"shares":6067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":6067,"derivative":{"exercise_price":217.2,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6067},"source":{"system":"sec-edgar","filing":"0001209191-21-029869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121029869/doc4.xml","form_type":"4"}},{"id":376769,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-04-16T20:06:40.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":198.711,"price":220.17,"value":43750.20087,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":13021.346,"derivative":{"underlying":"Common Stock","underlying_shares":198.711},"source":{"system":"sec-edgar","filing":"0001209191-21-026943","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121026943/doc4.xml","form_type":"4"}},{"id":381575,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-01-19T21:42:58.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":193.593,"price":225.99,"value":43750.08207,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":12822.635,"derivative":{"underlying":"Common Stock","underlying_shares":193.593},"source":{"system":"sec-edgar","filing":"0001209191-21-004033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121004033/doc4.xml","form_type":"4"}},{"id":383977,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T13:18:00.000Z","date":"2020-11-10","kind":"purchase","acquired":true,"shares":3905,"price":218.79,"value":854374.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market purchases reported on this line occurred at a weighted average price of $218.79 (range $218.21 to $219.00)."}],"balance_after":26210,"source":{"system":"sec-edgar","filing":"0001209191-20-057828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057828/doc4.xml","form_type":"4"}},{"id":383976,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T13:18:00.000Z","date":"2020-11-10","kind":"purchase","acquired":true,"shares":4270,"price":217.49,"value":928682.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market purchases reported on this line occurred at a weighted average price of $217.49 (range $217.05 to $218.04)."}],"balance_after":22305,"source":{"system":"sec-edgar","filing":"0001209191-20-057828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057828/doc4.xml","form_type":"4"}},{"id":383975,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T13:18:00.000Z","date":"2020-11-10","kind":"purchase","acquired":true,"shares":6825,"price":216.47,"value":1477407.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $216.47 (range $216.01 to $217.00)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":18035,"source":{"system":"sec-edgar","filing":"0001209191-20-057828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057828/doc4.xml","form_type":"4"}},{"id":384809,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2020-10-19T20:15:16.000Z","date":"2020-10-15","kind":"grant","acquired":true,"shares":196.356,"price":222.81,"value":43750.08036,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":12629.042,"derivative":{"underlying":"Common Stock","underlying_shares":196.356},"source":{"system":"sec-edgar","filing":"0001209191-20-055264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120055264/doc4.xml","form_type":"4"}},{"id":388230,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2020-07-17T20:13:09.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":155.253,"price":292.77,"value":45453.42081,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":12432.686,"derivative":{"underlying":"Common Stock","underlying_shares":155.253},"source":{"system":"sec-edgar","filing":"0001209191-20-042801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042801/doc4.xml","form_type":"4"}},{"id":389770,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T20:36:16.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":4527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":4527,"derivative":{"exercise_price":286.27,"expiration_date":"2030-05-31","underlying":"Common Stock","underlying_shares":4527},"source":{"system":"sec-edgar","filing":"0001209191-20-034049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120034049/doc4.xml","form_type":"4"}},{"id":390919,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":390918,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":59.55,"expiration_date":"2022-05-31","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":390917,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":2960,"price":272.46,"value":806481.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $272.46 (range $272.21 to $272.94)."}],"balance_after":11210,"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":390916,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":6232,"price":271.63,"value":1692798.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $271.63 (range $271.17 to $272.14)."}],"balance_after":14170,"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":390915,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":5889,"price":270.49,"value":1592915.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $270.49 (range $270.09 to $271.08)."}],"balance_after":20402,"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":390914,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":15751,"price":269.53,"value":4245367.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $269.53 (range $269.06 to $270.04)."}],"balance_after":26291,"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":390913,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":11568,"price":268.65,"value":3107743.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $268.65 (range $268.06 to $269.03)."}],"balance_after":42042,"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":390912,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":2600,"price":267.5,"value":695500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $267.50 (range $267.06 to $268.03)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":53610,"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":390911,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":22500,"price":81.54,"value":1834650.0,"ownership":{"direct":true},"balance_after":56210,"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":390910,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:24:51.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":22500,"price":59.55,"value":1339875.0,"ownership":{"direct":true},"balance_after":33710,"source":{"system":"sec-edgar","filing":"0001209191-20-027901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027901/doc4.xml","form_type":"4"}},{"id":391816,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2020-04-17T20:12:11.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":178.876,"price":258.56,"value":46250.17856,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":12277.433,"derivative":{"underlying":"Common Stock","underlying_shares":178.876},"source":{"system":"sec-edgar","filing":"0001209191-20-024786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120024786/doc4.xml","form_type":"4"}},{"id":396008,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":53.85,"expiration_date":"2021-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":396007,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":100,"price":235.4,"value":23540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."}],"balance_after":11210,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":396006,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":900,"price":234.15,"value":210735.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Open market sales reported on this line occurred at a weighted average price of $234.15 (range $233.77 to $234.66)."}],"balance_after":11310,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":396005,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":1800,"price":233.13,"value":419634.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Open market sales reported on this line occurred at a weighted average price of $233.13 (range $232.69 to $233.49)."}],"balance_after":12210,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":396004,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":1200,"price":232.04,"value":278448.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Open market sales reported on this line occurred at a weighted average price of $232.04 (range $231.45 to $232.42)."}],"balance_after":14010,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":396003,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":1200,"price":230.87,"value":277044.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Open market sales reported on this line occurred at a weighted average price of $230.87 (range $230.32 to $231.23)."}],"balance_after":15210,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":396002,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":500,"price":229.9,"value":114950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $229.90 (range $229.16 to $230.12)."}],"balance_after":16410,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":396001,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":600,"price":228.33,"value":136998.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $228.33 (range $227.97 to $228.78)."}],"balance_after":16910,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":396000,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":300,"price":227.66,"value":68298.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $227.66 (range $227.62 to $227.70)."}],"balance_after":17510,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":395999,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":5644,"price":227.01,"value":1281244.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $227.01 (range $226.70 to $227.59)."}],"balance_after":17810,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":395998,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":4198,"price":226.32,"value":950091.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $226.32 (range $225.62 to $226.60)."}],"balance_after":23454,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":395997,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":1858,"price":224.98,"value":418012.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $224.98 (range $224.66 to $225.21)."}],"balance_after":27652,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":395996,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":1700,"price":224.02,"value":380834.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $224.02 (range $223.58 to $224.40)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":29510,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":395995,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T21:15:33.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":20000,"price":53.85,"value":1077000.0,"ownership":{"direct":true},"balance_after":31210,"source":{"system":"sec-edgar","filing":"0001209191-20-006298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120006298/doc4.xml","form_type":"4"}},{"id":396751,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2020-01-17T21:13:10.000Z","date":"2020-01-15","kind":"grant","acquired":true,"shares":199.741,"price":231.55,"value":46250.02855,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":12098.557,"derivative":{"underlying":"Common Stock","underlying_shares":199.741},"source":{"system":"sec-edgar","filing":"0001209191-20-003955","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120003955/doc4.xml","form_type":"4"}},{"id":399665,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2019-10-17T20:07:54.000Z","date":"2019-10-15","kind":"grant","acquired":true,"shares":263.533,"price":175.5,"value":46250.0415,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":11898.816,"derivative":{"underlying":"Common Stock","underlying_shares":263.533},"source":{"system":"sec-edgar","filing":"0001209191-19-053410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119053410/doc4.xml","form_type":"4"}},{"id":401448,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2019-07-17T20:32:16.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":257.22,"price":176.39,"value":45371.0358,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":11635.283,"derivative":{"underlying":"Common Stock","underlying_shares":257.22},"source":{"system":"sec-edgar","filing":"0001209191-19-042388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119042388/doc4.xml","form_type":"4"}},{"id":402540,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2019-06-04T20:16:40.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":1801,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs's disability or death."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Mr. Sachs on June 1, 2018, Mr. Sachs deferred the receipt of 1,801 shares of common stock and received instead 1,801 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Mr. Sachs is reporting the disposition of 1,801 shares of common stock in exchange for an equal number of deferred stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs's disability or death."}],"balance_after":11378.063,"derivative":{"underlying":"Common Stock","underlying_shares":1801},"source":{"system":"sec-edgar","filing":"0001209191-19-034242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119034242/doc4.xml","form_type":"4"}},{"id":402539,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T20:16:40.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":6659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":6659,"derivative":{"exercise_price":168.04,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":6659},"source":{"system":"sec-edgar","filing":"0001209191-19-034242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119034242/doc4.xml","form_type":"4"}},{"id":402538,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T20:16:40.000Z","date":"2019-06-01","kind":"disposition_to_issuer","acquired":false,"shares":1801,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Mr. Sachs on June 1, 2018, Mr. Sachs deferred the receipt of 1,801 shares of common stock and received instead 1,801 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Mr. Sachs is reporting the disposition of 1,801 shares of common stock in exchange for an equal number of deferred stock units."}],"balance_after":11210,"source":{"system":"sec-edgar","filing":"0001209191-19-034242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119034242/doc4.xml","form_type":"4"}},{"id":404095,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2019-04-17T20:42:54.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":246.873,"price":182.28,"value":45000.01044,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":9577.063,"derivative":{"underlying":"Common Stock","underlying_shares":246.873},"source":{"system":"sec-edgar","filing":"0001209191-19-025000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119025000/doc4.xml","form_type":"4"}},{"id":409032,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2019-01-16T21:52:55.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":243.375,"price":184.9,"value":45000.0375,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":9330.19,"derivative":{"underlying":"Common Stock","underlying_shares":243.375},"source":{"system":"sec-edgar","filing":"0001209191-19-003955","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119003955/doc4.xml","form_type":"4"}},{"id":409570,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T21:58:13.000Z","date":"2018-12-28","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift to a charitable foundation."}],"balance_after":13011,"source":{"system":"sec-edgar","filing":"0001209191-19-000315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119000315/doc4.xml","form_type":"4"}},{"id":409973,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-07T21:06:55.000Z","date":"2018-12-06","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":34.24,"expiration_date":"2020-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-061479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118061479/doc4.xml","form_type":"4"}},{"id":409972,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-07T21:06:55.000Z","date":"2018-12-06","kind":"exercise","acquired":true,"shares":10000,"price":34.24,"value":342400.0,"ownership":{"direct":true},"balance_after":23011,"source":{"system":"sec-edgar","filing":"0001209191-18-061479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118061479/doc4.xml","form_type":"4"}},{"id":411283,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2018-10-17T13:44:29.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":250.991,"price":179.29,"value":45000.17639,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":9086.815,"derivative":{"underlying":"Common Stock","underlying_shares":250.991},"source":{"system":"sec-edgar","filing":"0001209191-18-055214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118055214/doc4.xml","form_type":"4"}},{"id":413448,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14205,"kind":"person","name":"SACHS BRUCE I","position":1,"cik":"0001197036","reported_name":"SACHS BRUCE I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2018-07-18T21:23:46.000Z","date":"2018-07-16","kind":"grant","acquired":true,"shares":248.66,"price":180.97,"value":45000.0002,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death."}],"balance_after":8835.824,"derivative":{"underlying":"Common Stock","underlying_shares":248.66},"source":{"system":"sec-edgar","filing":"0001209191-18-043122","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118043122/doc4.xml","form_type":"4"}}],"next_cursor":"2018-07-18T21:23:46.000000Z,413448"}